Skip to main content

Advertisement

Log in

Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2

References

  1. Baccarani M, Saglio J, Goldman J, Hochhaus A, Simonsson B, Appelbaum F, et al., European Leukemia Net. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 2006; 108: 1809–1820.

    Article  CAS  PubMed  Google Scholar 

  2. Kantarjian H, Pasquini R, Hamerschlak N, Rousselot P, Holowiecki J, Jootar S et al. Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial. Blood 2007; 109: 5143–5150.

    Article  CAS  PubMed  Google Scholar 

  3. Basciani S, Mariani S, Arizzi M, Ulisse S, Rucci N, Jannini EA et al. Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B, and PDGF receptor-alpha and –beta during human testicular development and disease. J Clin Endocrinol Metab 2002; 87: 2310–2319.

    CAS  PubMed  Google Scholar 

  4. Cheng J, Watkins SC, Walker WH . Testosterone activates mitogen-activated protein kinase via Src kinase and the epidermal growth factor receptor in Sertoli cells. Endocrinology 2007; 148: 2066–2074.

    Article  CAS  PubMed  Google Scholar 

  5. Gambacorti-Passerini C, Tornaghi L, Cavagnini F, Rossi P, Pecori-Giraldi F, Mariani L et al. Gynaecomastia in men with chronic myeloid leukemia after imatinib. Lancet 2003; 361: 1954–1956.

    Article  PubMed  Google Scholar 

  6. Kim H, Chang HM, Ryu MH, Kim TW, Sohn HJ, Kim SE et al. Concurrent male gynecomastia and testicular hydrocele after imatinib mesylate treatment of a gastrointestinal stromal tumor. J Korean Med Sci 2005; 20: 512–515.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Walz C, Sattler M . Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML). Critic Rew Oncol Hematol 2006; 57: 145–164.

    Article  Google Scholar 

  8. Sprenkle PC, Fish H . Pathologic effects of testosterone deprivation. Curr Opin Urol 2007; 17: 424–430.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G Caocci.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caocci, G., Atzeni, S., Orrù, N. et al. Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia. Leukemia 22, 2127–2128 (2008). https://doi.org/10.1038/leu.2008.106

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2008.106

  • Springer Nature Limited

This article is cited by

Navigation